The invention provides combination therapy, wherein one or more other therapeutic agents are administered agents are administered with peptide epoxyketones or a pharmaceutically acceptable salt thereof. Another aspect of the invention relates to treating cancer with a peptide epoxyketone administered in combination with another therapeutic agent.
申请公布号
WO2010048298(A1)
申请公布日期
2010.04.29
申请号
WO2009US61498
申请日期
2009.10.21
申请人
PROTEOLIX, INC.;KIRK, CHRISTOPHER, J.;DEMO, SUSAN, D.;BENNETT, MARK, K.
发明人
KIRK, CHRISTOPHER, J.;DEMO, SUSAN, D.;BENNETT, MARK, K.
